No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Sirolimus, also known as rapamycin, is an immunosuppressive drug used to prevent organ rejection in transplant patients. It works by inhibiting the activity of T-cells, which are responsible for attacking foreign bodies. Sirolimus is also used to treat certain types of cancer, such as lymphoma and Kaposi's sarcoma. It is often used in combination with other immunosuppressive drugs, such as cyclosporine and tacrolimus.
Sirolimus is available in both oral and intravenous formulations. It is generally well-tolerated, with the most common side effects being nausea, vomiting, and diarrhea. It is also associated with an increased risk of infection and certain types of cancer.
The sirolimus market is highly competitive, with several major players. These include Pfizer, Novartis, Merck, and Astellas. Other companies, such as Mylan and Teva, also offer generic versions of the drug. Show Less Read more
